The American Medical Association passed its first policy addressing augmented intelligence in the healthcare industry during its annual meeting in Chicago, which ran June 7 to June 13.

The policy suggests tasks for the AMA to address regarding the use of AI in healthcare, with a focus on encouraging healthcare stakeholders and federal policymakers to prioritize “user-centered design.” The initiative builds on a proposed a “baseline policy” the association laid out in a May report to its board of trustees.

Under the new policy, the AMA will set priorities for AI development focused on patient outcomes and physician satisfaction, integrate the perspective of practicing physicians into the technology’s design, and promote greater understanding of the potential and limitations of AI across the industry.

“Combining AI methods and systems with an irreplaceable human clinician can advance the delivery of care in a way that outperforms what either can do alone,” AMA Board Member Jesse M. Ehrenfeld, MD, said in a June 14 statement. “But we must forthrightly address challenges in the design, evaluation and implementation as this technology is increasingly integrated into physicians’ delivery of care to patients.”

The promise of augmented intelligence in spurring technological innovation in medicine has generated interest among health care stake holders. With that interest, comes concern. CLICK HERE to learn more about how BHM helps your organization build resources while focusing on patient/member experiences.